SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-6 POS - Post-effective amendments for immediately effective filing:
SEC Accession No. 0001193805-20-000840
Filing Date
2020-07-14
Accepted
2020-07-14 15:19:31
Documents
4
Effectiveness Date
2020-07-14

Document Format Files

Seq Description Document Type Size
1 e619784_f6pos-tls.htm F-6 POS 62752
2 e619784_ex99-a3.htm EX-99.(A)(3) 110406
3 e619784_ex99-e.htm EX-99.(E) 2893
4 GRAPHIC image.jpg GRAPHIC 83566
  Complete submission text file 0001193805-20-000840.txt   292909
Mailing Address 383 MADISON AVENUE 11TH FLOOR NEW YORK NY 10179
Business Address 383 MADISON AVENUE 11TH FLOOR NEW YORK NY 10179 212-319-7600
JPMorgan Chase Bank, N.A. - ADR Depositary (Filed by) CIK: 0001474274 (see all company filings)

IRS No.: 000000000 | State of Incorp.: OH | Fiscal Year End: 1231
Type: F-6 POS
SIC: 8880 American Depositary Receipts

Mailing Address 3RD FLOOR, 11-12 ST. JAMES'S SQUARE LONDON, ENGLAND X0 SW1Y 4LB
Business Address 3RD FLOOR, 11-12 ST. JAMES'S SQUARE LONDON, ENGLAND X0 SW1Y 4LB 0044(0) 207-495-2379
Tiziana Life Sciences plc (Subject) CIK: 0001723069 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: F-6 POS | Act: 33 | File No.: 333-227509 | Film No.: 201027108
SIC: 2834 Pharmaceutical Preparations